2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

¡®ÇÏÆ®Æä¾î¸µ¡¯ Æä¾î¸µºÏ, 33°¡Áö Áú¹®ÀÇ ´äÀÌ Ã¥ÀÌ µÆ´Ù

½Ì±ÛÀÎ ÀÌû¾Æ, Ãֽÿø, ¹Ì¹Ì ´äº¯ÀÌ ±Ã±ÝÇÒ Á¤µµ·Î °¡Ä¡ Àִ å
ä³ÎA »õ ¿¬¾Ö ¿¹´É ‘ÇÏÆ®Æä¾î¸µ’ÀÌ Ã¹ ÃÔ¿µºÎÅÍ ‘°ú¸ôÀÔ’¿¡ ºüÁø 5MC À±Á¾½Å-ÀÌû¾Æ-Ãֽÿø-¹Ì¹Ì-¹ÚÁö¼± ±³¼öÀÇ ½ºÆ©µð¿À ÃÔ¿µ ½ºÆ¿À» °ø°³Çß´Ù. 3¿ù 7ÀÏ(±Ý) ¹ã 10½Ã 50ºÐ ù ¹æ¼ÛÇϴ ä³ÎA ‘ÇÏÆ®Æä¾î¸µ’Àº °áÈ¥ÇÏ°í ½ÍÀº ûÃáµéÀÇ ³¶¸¸°ú ÇöŸ Ãæ¸¸ÇÑ È¥Àü ¿¬¾Ö Àϱ⸦ ±×·Á³»´Â ¿¬¾Ö ÇÁ·Î±×·¥ÀÌ´Ù. ÀÌÁ¦´Â °áÈ¥ÇÒ »ç¶÷°ú ¿¬¾ÖÇÏ°í ½ÍÀº ûÃá³²³àµéÀÌ ´Ü¼øÇÑ ‘½æ’À» ³Ñ¾î, °áÈ¥ »ó´ë¸¦ ã±â À§ÇØ ÁøÁöÇÏ°Ô ¼­·Î¸¦ ¾Ë¾Æ°¡´Â °úÁ¤À» ´ã¾Æ³½´Ù. Ã⿬ÁøµéÀº Áö³­ÇØ ¸» ¾Æ¸§´Ù¿î ³¶¸¸ ...
Tourism in Asia and the Pacific Reach 85% of 2019 Levels, Wi... (2024-12-15)
Æ®·ÎÆ® °¡¼ö ¹Ú±Ô¸®, µð¿£¾¾ ÀÌ¿£Æ¼¿Í Àü¼Ó°è¾à (2024-11-17)
¾ÆÀÌ¿¥¹ðÅ©-´ë±¸´ë, ¸ð¹ÙÀÏ Ç÷§Æû ¡®¾ÆÀÌ¿¥ À¯´ÏÁ ±¸Ãà Çù... (2024-10-20)
'ÀÎõ XR Àü¹®Àη ¾ç¼º±³À°¡¯ ÀçÁ÷ÀÚ ´Ü±â°úÁ¤ °³¼³ (2024-11-08)
Áö½Ä ³ª´® ¹®È­°­¿¬ ÅëÇÑ ¼öÀÍ±Ý ÀÚ¸³Áغñû³â ÈÄ¿ø (2024-11-08)
¸Á°í½½·¡ºê ¡®³×¸ð´ÐAI¡¯, »ý¼ºÇü AI Á¢¸ñÇÑ ¸Þ¸ð ÇÁ¸°ÅÍ °ø°³ (2024-06-21)
ÀÌ¿ø±â ÀÛ°¡ÀÇ ÃÊ¿¬°áÀûÀÎ Àü½Ã ¡®¾î¸Ó´Ï Àü»ó¼­¡¯ (2024-10-02)
»ç¸ðÁÖ½Ä ÅõÀÚÀÚµé ³«°ü·Ð È®´ë, º¥Ã³Ä³ÇÇÅ» Àü¸ÁÀº »ó½Â¼¼ Àü¸Á (2025-01-22)
À¯¼¼¸°, 1¿ù ÇÑ ´Þ°£ ¡®¿Ã¸®ºê¿µ °­³²Å¸¿îÁ¡¡¯ ÆË¾÷½ºÅä¾î ÁøÇà (2025-01-22)
³ó¸²Ãà»ê½ÄǰºÎ-ÇѽÄÁøÈï¿ø, ÇÑ½Ä ºê·£µù ·Î°í µðÀÚÀÎ °ø¸ðÀü (2024-08-26)
±¹ÅäºÎ, °¡½º1Á¾Àº Ư¼ö¾÷Á¾ÀÓ¿¡µµ ºñȸ¿ø µ¿ÀǼ­ ¿ä±¸ (2024-09-23)
ÇÔ²²ÇÏ´Â Çѽ£°ú À²ÃÌÈ­ÇÐ, ±èÀå ³ª´® ºÀ»çȰµ¿ (2024-12-16)
±Á³×, Ãß¼® ¸Â¾Æ ¡®Ä«Ä«¿À¼îÇζóÀ̺ꡯ¿Í ¡®±ÁÀ§Å©¡¯ ÇÁ·Î¸ð¼Ç (2024-09-14)
ÅëÀϺÎ, ÅëÀÏ ¿°¿ø û¼Ò³â ¹Ì¼ú °ø¸ðÀü °³ÃÖ (2024-09-24)
¼­´ë¹®Ã»¼Ò³â¼¾ÅÍ µµ½Ã¼ÓÀÛÀºÇб³, 1:1 Áö¿ª¿¬°è ÀÎÅÏ½Ê (2024-08-18)
GS25 ¡®¼¿ÇÁÇü ½º¹«µð¡¯·Î ¸Ô°Å¸® °æÀï·Â Ű¿î´Ù (2024-12-17)
ÀÎÅõ½ºÄ«ÀÌ, Àå¾Ö¹° ȸÇÇ¿Í ¿øÅÍÄ¡·Î Çõ½Å¡¦ ±¹»ê µå·ÐÀÇ ºñ»ó (2024-12-17)
¿¡¾îºô¸®Æ¼, ½Ì°¡Æ÷¸£¿Í ¹Ì±¹¿¡¼­ ±Û·Î¹ú ³×Æ®¿öÅ© È®´ë (2024-11-10)
¡®ÇÁ¶û½º ÆÐ¹Ð¸®¡¯ ±è´Ù¼±X½ºÆ¼ºê, ³ªÆú·¹¿Ë¡¤·Î´ó¡¤¹Ð·¹ ¹ßÀÚÃë... (2024-10-04)
Çö´ë·ÎÅÛ, ÷´Ü ¹«ÀÎ ¼Ò¹æ·Îº¿ ÃÖÃÊ °ø°³ (2024-11-01)
MBK Partners and Young Poong on the Verge of Victory in the ... (2025-03-20)
SBC Medical Group Co., Ltd. Sells Two Subsidiaries (2025-01-05)
°æ»ó³²µµ-â¿øÆ¯·Ê½Ã ¡®Á¦1ȸ ±¹Á¦¿ìÁÖÇ×°ø±â¼ú´ëÀü¡¯ °³ÃÖ (2024-10-23)
»ï¼ºÀüÀÚ, KES 2024¼­ ¸ðµÎ¸¦ À§ÇÑ ¡®AI ¶óÀÌÇÁ¡¯ Á¦¾È (2024-10-23)
¼ÒºñÀÚ 36%, ¼öÀÔǰ ±¸¸Å ÁöÃ⠴÷Á (2024-08-10)
       [ÀÌÀü][1]....[384][385][386][387][388][389][390][391][392]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..